Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.74%
|
$330,000
$11.35 P/Share
|
|
Nov 11
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
30,500
-24.71%
|
$396,500
$13.42 P/Share
|
|
Nov 11
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
6,920
-0.61%
|
$89,960
$13.73 P/Share
|
|
Nov 11
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.54%
|
$1,170,000
$13.42 P/Share
|
|
Nov 04
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
20,500
-5.45%
|
$266,500
$13.06 P/Share
|
|
Nov 01
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.18%
|
$54,000
$12.98 P/Share
|
|
Oct 31
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
36,197
-22.68%
|
$434,364
$12.04 P/Share
|
|
Oct 29
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
4,483
-2.73%
|
$53,796
$12.01 P/Share
|
|
Oct 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.71%
|
$300,000
$10.77 P/Share
|
|
Oct 14
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
30,500
-15.67%
|
$335,500
$11.5 P/Share
|
|
Oct 09
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.42%
|
$990,000
$11.33 P/Share
|
|
Oct 08
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
39,320
-16.81%
|
$471,840
$12.04 P/Share
|
|
Oct 08
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,460
-4.04%
|
$247,060
$11.03 P/Share
|
|
Oct 02
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
9,125
-3.75%
|
$100,375
$11.01 P/Share
|
|
Oct 01
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
21,375
-4.13%
|
$213,750
$10.75 P/Share
|
|
Oct 01
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
667
-0.18%
|
$7,337
$11.79 P/Share
|
|
Sep 17
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
16,413
-1.42%
|
$180,543
$11.77 P/Share
|
|
Sep 16
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
30,000
-1.68%
|
$330,000
$11.7 P/Share
|
|
Sep 16
2024
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.31%
|
$990,000
$11.7 P/Share
|
|
Sep 13
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
14,500
-5.2%
|
$174,000
$12.0 P/Share
|
|
Sep 13
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.11%
|
$300,000
$12.0 P/Share
|
|
Sep 12
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
120,500
-30.17%
|
$1,325,500
$11.0 P/Share
|
|
Sep 12
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.07%
|
$275,000
$11.0 P/Share
|
|
Sep 12
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
25,000
-6.17%
|
$275,000
$11.48 P/Share
|
|
Sep 11
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
8,561
-2.1%
|
$85,610
$10.01 P/Share
|
|
Sep 11
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
34,626
-4.41%
|
$311,634
$9.73 P/Share
|
|
Sep 05
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
4,789
-1.16%
|
$47,890
$10.0 P/Share
|
|
Sep 05
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
4,541
-1.12%
|
$45,410
$10.0 P/Share
|
|
Sep 04
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,650
-0.2%
|
$16,500
$10.01 P/Share
|
|
Sep 04
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
1,300
-0.32%
|
$13,000
$10.0 P/Share
|
|
Aug 23
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
2,926
-0.16%
|
$26,334
$9.06 P/Share
|
|
Aug 22
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
7,074
-0.39%
|
$63,666
$9.02 P/Share
|
|
Aug 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.1%
|
$160,000
$8.7 P/Share
|
|
Aug 14
2024
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.83 P/Share
|
|
Aug 02
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
1,333
-0.16%
|
$11,997
$9.01 P/Share
|
|
Jul 19
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
36,700
-1.98%
|
$367,000
$10.01 P/Share
|
|
Jul 19
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
38,858
-8.57%
|
$388,580
$10.01 P/Share
|
|
Jul 18
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
40,137
-1.06%
|
$401,370
$10.01 P/Share
|
|
Jul 18
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
44,042
-8.86%
|
$440,420
$10.0 P/Share
|
|
Jul 17
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
23,163
-1.21%
|
$231,630
$10.0 P/Share
|
|
Jul 17
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-1.01%
|
$250,000
$10.01 P/Share
|
|
Jul 17
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
22,100
-4.25%
|
$221,000
$10.0 P/Share
|
|
Jul 16
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
25,000
-5.81%
|
$225,000
$9.98 P/Share
|
|
Jul 15
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
22,400
-1.78%
|
$201,600
$9.06 P/Share
|
|
Jul 15
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
15,034
-3.56%
|
$135,306
$9.05 P/Share
|
|
Jul 15
2024
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.94 P/Share
|
|
Jul 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
39,700
-2.03%
|
$357,300
$9.04 P/Share
|
|
Jul 12
2024
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
2,600
-0.21%
|
$23,400
$9.0 P/Share
|
|
Jul 12
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
300
-0.07%
|
$2,700
$9.0 P/Share
|
|
Jul 12
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
300
-0.02%
|
$2,700
$9.0 P/Share
|